- Moolec Science (MLEC, Financial) announces a transformational all-stock business combination with Bioceres Group and other entities.
- The transaction will issue up to 87 million new shares and 5 million warrants, expanding Moolec's portfolio to over 800 patents and more than $500 million in annual sales.
- The deal is expected to close in Q2 2025, pending shareholder approval and other conditions.
Moolec Science (MLEC) has entered into a transformational all-stock business combination agreement with Bioceres Group, Nutrecon, and Gentle Technologies Corp. As part of this deal, Moolec will issue up to 87 million new shares and 5 million warrants to acquire these entities, significantly broadening its technological horizon and market presence.
The newly created company will manage a vast portfolio of over 800 patents and 550 product registrations, which together represent more than half a billion dollars in annual sales dispersed across more than 50 countries. This aligns Moolec as a comprehensive agricultural technology company, integrating advanced molecular farming, biological inputs, and climate-resilient seeds.
Key aspects of this transaction include the continued development of molecular farming products like Piggy Sooy™ and GLASO™, the integration of biological agricultural solutions via Bioceres Group, and an expansion into R&D and CDMO services under the Agrality® and Synbio Powerlabs® brands. Additionally, the venture will explore emerging technologies in biomaterials and farm equipment.
The transaction is anticipated to conclude in the second quarter of 2025, contingent upon shareholder approval and completion of a reverse stock split, along with other regulatory conditions. CEO GastĂłn Paladini will step down following the Extraordinary General Meeting on April 22, 2025.
